Howard J. Siegel - 25 Jun 2026 Form 4 Insider Report for CME GROUP INC. (CME)

Reporting relationship: Director
Issuer ticker: CME
Reported as of: 25 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 29 Jun 2026, 16:24:20 UTC
Prior SEC filing: 26 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Elizabeth Hensen, as Attorney-in-Fact for Howard J. Siegel

Key filing fact

Howard J. Siegel filed Form 4 for CME GROUP INC. (CME) on 29 Jun 2026.

Key facts

This page summarizes Howard J. Siegel's Form 4 filing for CME GROUP INC. (CME).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 29 Jun 2026, 16:24.

Change

Previous filing in this sequence was filed on 26 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001212853 Primary reporting owner

SIEGEL HOWARD J

Relationship: Director
Address: 20 S. WACKER DRIVE, CHICAGO
Signature: /s/ Elizabeth Hensen, as Attorney-in-Fact for Howard J. Siegel
Signature date: 29 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CME transaction

Common Stock Class A

Award

Transaction value
Shares: +645
Change %: +1.3%
Price: $225.00^*
Shares after: 48,436
Date: 25 Jun 2026
Ownership: Direct
Footnotes: F1

CME transaction

Common Stock Class A

Award

Transaction value
Shares: +422
Change %: +0.87%
Price: $225.00^*
Shares after: 48,858
Date: 25 Jun 2026
Ownership: Direct
Footnotes: F2

CME holding

Common Stock Class A

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 21,873
Date: 25 Jun 2026
Ownership: by Trust

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.

Footnote F2

At the Reporting Person's election, shares issued in lieu of all or a portion of the annual cash retainer for serving as a member of the Board of Directors. The number of shares was determined by dividing the cash retainer by the closing price on the date of grant.